Ticker Symbol: VIR
Vir Biotechnology Inc
$33.42 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001706431
Company Profile
Vir Biotechnology is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of product candidates targeting SARS-CoV-2, hepatitis B virus, influenza A, human immunodeficiency virus and tuberculosis.
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2836
Address: N/A
Website: www.vir.bio
CEO: N/A
Tags:
- Commercial Services
- Miscellaneous Commercial Services
- Health Technology
- Biotechnology
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $9.18
Change:
$0.19
(
2.11%)
Days Range: $8.91 - $9.19
Beta: 1.14
52wk. High: $31.55
52wk. Low: $8.09
Ytd. Change -62.37%
50 Day Moving Average: $9.46
200 Day Moving Average: $18.39
Shares Outstanding: 134251320
Valuation
Market Cap: 123.2B
PE Ratio: -4.73
EPS (TTM): -1.94
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A